Biphosphonates in Metastatic Bone Disease of Neuroendocrine Neoplasms Abstract #1862

Introduction: Metastatic bone disease (mBD) in patients with neuroendocrine neoplasms (NENs) is associated with a more aggressive behaviour
Aim(s): Their response to first line treatment with biphosphonates
Materials and methods: We studied 554 patients (259 females) with NEΝs: 94 gastric, 27 duodenal, 201 pancreatic, 70 small intestine, 42 appendiceal, 28 colic, 39 lung, 1 thymic, 32 unknown primary origin (UPO) and 16 elsewhere. Since September 2012 16 patients with NENs and mBD were recruited to receive 4mg of zoledronic acid monthly for 2 consecutive years; they were all followed-up by biochemical parameters and bone scan every 6 months
Conference: 14th Annual ENETS conference (2017)
Category: Medical treatment - Others
Presenting Author: MD Krystallenia Alexandraki
Keywords: bone disease

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1876 Multiple Endocrine Neoplasia Type 1 (MEN1): The Experience of a Referral Center in Greece
Introduction: Multiple endocrine neoplasia type 1 (MEN1) is a genetic disorder involving mainly parathyroid, pituitary and pancreatic neuroendocrine neoplasms (pNENs)
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: MD Krystallenia Alexandraki
Keywords: MEN1
#1143 Ectopic Cushing’s Syndrome (ECS) in Patients with Neuroendocrine Neoplasms
Introduction: Ectopic Cushing syndrome (ECS) has been described in patients with neuroendocrine neoplasms (NENs)
Conference: 12th Annual ENETS Conference (2015)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: MD Krystallenia Alexandraki
Keywords: ECS
#1535 VIPomas, a Rare Entity
Introduction: VIP secreting pancreatic neuroendocrine tumors(pNETs) are rare and controlled studies are lacking.
Conference: 13th Annual ENETS conference (2016)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: MD,PhD Georgios Boutzios
Keywords: VIPoma, pNET
#1935 Prevalence of Pancreatic Neuroendocrine Neoplasms with Serotonin Secretion
Introduction: Pancreatic neuroendocrine neoplasms (pNENs) are rare neoplasms and represent 1-2% of all pancreatic neoplasms. These tumors can secrete a variety of hormonally active substances producing distinct clinical symptoms, or can be clinically non-functioning. Pancreatic NENs that secrete serotonin are extremely rare, but their prevalence has not been explored adequately.
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: MD, MSc, PhD Nikolaos Tsoukalas
#1880 Dedifferentiation of Metastatic Pancreatic Neuroendocrine Neoplasms
Introduction: Neuroendocrine neoplasms (NENs) exhibit significant differences in growth behavior. Their metastatic disease may dedifferentiate presenting a more aggressive biological behavior
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: MD Krystallenia Alexandraki